Diversity Supplement for: Mechanisms for Regenerative Healing in Intervertebral Discs
多样性补充:椎间盘再生愈合机制
基本信息
- 批准号:10631488
- 负责人:
- 金额:$ 3.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdhesivesAdultAnatomyAnimalsBack PainBiocompatible MaterialsBiologicalBiological ProcessBiomechanicsBiomedical EngineeringCarboxymethylcelluloseCell Adhesion MoleculesCellsChemicalsCitiesCollaborationsCollagenDefectDevelopmentDoctor of PhilosophyElementsEngineeringFibrinFibronectinsGoldHuman Anti-Mouse AntibodyHyaluronic AcidHydrogelsInjectableInjuryIntervertebral disc structureJointsLearningMechanicsMentorsMethacrylatesMethodsModelingNeonatalNew YorkOrgan Culture TechniquesOxidesPainRecurrent painResearchRiskScientistTissuesTrainingTraining ActivityUnderrepresented Studentscareercareer developmentcollegecovalent bonddesigndisabilitydisability impactdisc regenerationhealinginjury and repairintervertebral disk degenerationmeetingsnucleus pulposusparent grantpoly(ethylene glycol)diacrylatepre-doctoralprogramsrecruitregenerativerepair strategyrepairedsealantstandard care
项目摘要
PROJECT SUMMARY
Back pain is a leading cause of global disability impacting >100 million US adults. Poor IVD healing results in
structural IVD defects that accumulate to result in herniation, degeneration, and anatomical disruptions that
cause disability and pain. A critical unmet need is to develop annulus fibrosus (AF) repair strategies since no
treatments exist and discectomy, the gold standard treatment for nucleus pulposus (NP) herniation, leaves AF
defects unrepaired with complications including reherniation and recurrent pain. The parent grant focuses on
understanding fundamental cellular and mechanobiological factors that enable regenerative healing in neonatal
IVDs. The Diversity Supplement expands the scope of the parent grant in 2 highly significant ways. First, the
Diversity Supplement is translational focusing on developing an optimized 3D biomaterial carrier to deliver cells
that can promote adult IVD healing. Second, the career development activities of Ms. Sabrina Delva are
considered highly significant. By focusing the Aims of the Diversity Supplement on AF repair, this project
allows Ms. Delva to join the team of scientists involved in the parent grant enabling her to rapidly learn new
methods, gain confidence and advance her career with training activities. Aim 1 is to determine the effect of
biomaterial stiffness on IVD deformations and herniation risk. Our first biomaterial which is a newly developed
two-part repair strategy comprising a dual-modified (MethAcrylated and oxidized) Hyaluronic Acid (HAMA) and
injectable interpenetrating network hydrogel composed of fibronectin-conjugated fibrin and poly (ethylene
glycol) diacrylate (PEGDA), or HAMA-PEGDA. This material was selected since the HAMA chemically adsorbs
the PEGDA to integrate with the native AF tissue by covalently bonding to collagen. Our second biomaterial
adhesive is a newly developed Methacrylated and oxidized carboxymethylcellulose (MoCMC) which was
selected to be a thermogeling adhesive with hydrolytic stability and cytocompatibility. Aim 2 then adds
complexity by determining which biomaterial sealant strategy most effectively retains biomechanical and
biological function of large animal IVDs in organ culture injury models with biomechanical and biological
assessments. Aim 3 is to engineer mechanically optimized cell delivery biomaterials by modulating type and
concentration of cell adhesion molecules and macromer concentrations. The research and mentoring plans
are designed to provide Ms. Sabrina Delva with a rigorous, inspiring, and well-mentored PhD program. Key
elements are to provide Ms. Delva with substantial scientific training, extensive mentoring, coursework, and
professional development & networking. We expect Ms. Delva to present at least annually at annual meetings,
and to establish many collaborations across Mount Sinai and the City College of New York.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James C. Iatridis其他文献
P49. Physical activity measures in lumbar laminectomy patients: a prospective comparison of fitness tracker measures versus patient-reported outcome measures
- DOI:
10.1016/j.spinee.2020.05.447 - 发表时间:
2020-09-01 - 期刊:
- 影响因子:
- 作者:
Dennis M. Bienstock;Dhruv S. Shankar;Jinseong Kim;Nicole Zubizarreta;Jashvant Poeran;Wesley H. Bronson;Saad B. Chaudhary;James C. Iatridis - 通讯作者:
James C. Iatridis
TNFR1-mediated senescence and lack of TNFR2-signaling limit human intervertebral disc cell repair potential in degenerative conditions
在退变情况下,TNFR1介导的衰老以及TNFR2信号缺失限制了人椎间盘细胞的修复潜能
- DOI:
10.1016/j.joca.2025.02.791 - 发表时间:
2025-07-01 - 期刊:
- 影响因子:9.000
- 作者:
Jennifer Gansau;Elena Grossi;Levon Rodriguez;Minghui Wang;Damien M. Laudier;Saad Chaudhary;Andrew C. Hecht;Wenyu Fu;Robert Sebra;Chuan-Ju Liu;James C. Iatridis - 通讯作者:
James C. Iatridis
Does BMP-2 Really Cause Cancer? A Systematic Review of the Literature
- DOI:
10.1016/j.spinee.2012.08.375 - 发表时间:
2012-09-01 - 期刊:
- 影响因子:
- 作者:
Steven M. Koehler;James C. Iatridis;Andrew Hecht;Sheeraz Qureshi;Samuel K. Cho - 通讯作者:
Samuel K. Cho
Effect of the CCL5 releasing fibrin gel for intervertebral disc regeneration
- DOI:
7.10.1177/1947603518764263 - 发表时间:
2018 - 期刊:
- 影响因子:2.8
- 作者:
Zhiyu Zhou;Stephan Zeiter;Tanja Schmid;Daisuke Sakai;James C. Iatridis;Guangqian Zhou;R. Geoff Richards;Mauro Alini;Sibylle Grad;Zhen Li - 通讯作者:
Zhen Li
Trends in Bone Morphogenetic Protein (BMP) Usage Since the US Food and Drug (FDA) Advisory in 2008: What Happens to Physician Practices When the FDA Issues an Advisory?
- DOI:
10.1016/j.spinee.2013.07.299 - 发表时间:
2013-09-01 - 期刊:
- 影响因子:
- 作者:
Janay Mckie;Sheeraz A. Qureshi;James C. Iatridis;Natalia N. Egorova;Samuel K. Cho;Andrew Hecht - 通讯作者:
Andrew Hecht
James C. Iatridis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James C. Iatridis', 18)}}的其他基金
Mechanisms for Regenerative Healing in Intervertebral Discs
椎间盘再生愈合机制
- 批准号:
10344363 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Role of TNFalpha in discogenic pain progression and as a treatment target
TNFα 在椎间盘源性疼痛进展中的作用及其作为治疗靶点
- 批准号:
10557110 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Role of TNFalpha in discogenic pain progression and as a treatment target
TNFα 在椎间盘源性疼痛进展中的作用及其作为治疗靶点
- 批准号:
10755462 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Mechanisms for Regenerative Healing in Intervertebral Discs
椎间盘再生愈合机制
- 批准号:
10551336 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Role of TNFalpha in discogenic pain progression and as a treatment target
TNFα 在椎间盘源性疼痛进展中的作用及其作为治疗靶点
- 批准号:
10375766 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Mechanisms for Regenerative Healing in Intervertebral Discs
椎间盘再生愈合机制
- 批准号:
10762672 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Diversity Supplement for: Role of TNFalpha in discogenic pain progression and as a treatment target
多样性补充:TNFα 在椎间盘源性疼痛进展中的作用以及作为治疗目标
- 批准号:
10631481 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Diabetes Induced Disc Degeneration and Prevention
糖尿病引起的椎间盘退变及预防
- 批准号:
9185665 - 财政年份:2016
- 资助金额:
$ 3.13万 - 项目类别:
Diabetes Induced Disc Degeneration and Prevention
糖尿病引起的椎间盘退变及预防
- 批准号:
9293971 - 财政年份:2016
- 资助金额:
$ 3.13万 - 项目类别:
Notochordal Cell Derived Therapies for Painful Disc Degeneration
脊索细胞衍生疗法治疗疼痛性椎间盘退变
- 批准号:
8599568 - 财政年份:2013
- 资助金额:
$ 3.13万 - 项目类别:
相似海外基金
I-Corps: Translation Potential of Peptidic Ensembles as Novel Bio-adhesives
I-Corps:肽整体作为新型生物粘合剂的转化潜力
- 批准号:
2409620 - 财政年份:2024
- 资助金额:
$ 3.13万 - 项目类别:
Standard Grant
Architectural design of active adhesives
活性粘合剂的结构设计
- 批准号:
2403716 - 财政年份:2024
- 资助金额:
$ 3.13万 - 项目类别:
Standard Grant
Design of non-swellable adhesives for brain surgery using cyclodextrin inclusion polymer
使用环糊精包合物聚合物脑外科不可溶胀粘合剂的设计
- 批准号:
23H01718 - 财政年份:2023
- 资助金额:
$ 3.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Meta-material adhesives for improved performance and functionalisation of bondlines
超材料粘合剂可提高粘合层的性能和功能化
- 批准号:
EP/W019450/1 - 财政年份:2023
- 资助金额:
$ 3.13万 - 项目类别:
Fellowship
Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
- 批准号:
10741660 - 财政年份:2023
- 资助金额:
$ 3.13万 - 项目类别:
DMREF: Accelerating the Design of Adhesives with Nanoscale Control of Thermomechanical Properties
DMREF:通过热机械性能的纳米级控制加速粘合剂的设计
- 批准号:
2323317 - 财政年份:2023
- 资助金额:
$ 3.13万 - 项目类别:
Continuing Grant
Mag-Cure: A novel method for magnetically induced bonding and de-bonding of thermoset adhesives in the Automotive Industry
Mag-Cure:汽车行业中热固性粘合剂磁感应粘合和脱粘的新方法
- 批准号:
10062336 - 财政年份:2023
- 资助金额:
$ 3.13万 - 项目类别:
Collaborative R&D
Biodegradable, Biocompatible Pressure Sensitive Adhesives
可生物降解、生物相容性压敏粘合剂
- 批准号:
10677869 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Poly(glycerol carbonate) pressure sensitive adhesives for the in vivo closure of alveolar pleural fistulae
用于体内闭合肺泡胸膜瘘的聚(甘油碳酸酯)压敏粘合剂
- 批准号:
10746743 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Enhanced bio-production of difficult to make peptide ingredients for specialty adhesives and personal care
增强用于特种粘合剂和个人护理品的难以制造的肽成分的生物生产
- 批准号:
10021363 - 财政年份:2022
- 资助金额:
$ 3.13万 - 项目类别:
Investment Accelerator














{{item.name}}会员




